These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
332 related items for PubMed ID: 16308886
1. Plasma fatty acids and lipoproteins in type 2 diabetic patients. Lapolla A, Sartore G, Della Rovere GR, Romanato G, Zambon S, Marin R, Manzato E, Fedele D. Diabetes Metab Res Rev; 2006; 22(3):226-31. PubMed ID: 16308886 [Abstract] [Full Text] [Related]
2. Protective effect of rutin on lipids, lipoproteins, lipid metabolizing enzymes and glycoproteins in streptozotocin-induced diabetic rats. Stanely Mainzen Prince P, Kannan NK. J Pharm Pharmacol; 2006 Oct; 58(10):1373-83. PubMed ID: 17034661 [Abstract] [Full Text] [Related]
3. Lipoprotein alterations in hemodialysis: differences between diabetic and nondiabetic patients. González AI, Schreier L, Elbert A, Berg G, Beresan H, López G, Wikinski R. Metabolism; 2003 Jan; 52(1):116-21. PubMed ID: 12524671 [Abstract] [Full Text] [Related]
4. Effects of soybean D-LeciVita product on serum lipids and fatty acid composition in type 2 diabetic patients with hyperlipidemia. Ristić Medić D, Ristić V, Arsić A, Postić M, Ristić G, Blazencić Mladenović V, Tepsić J. Nutr Metab Cardiovasc Dis; 2006 Sep; 16(6):395-404. PubMed ID: 16935698 [Abstract] [Full Text] [Related]
5. Relationship between the concentrations of plasma phospholipid stearic acid and plasma lipoprotein lipids in healthy men. Li D. Clin Sci (Lond); 2001 Jan; 100(1):25-32. PubMed ID: 11115414 [Abstract] [Full Text] [Related]
6. [Comparative analysis of the lipid-protein spectrum of lipoproteins and fatty acid composition of lipids in plasma and erythrocytes of native populations of Chukotka and Moscow]. Gerasimova EN, Levachev MM, Ozerova IN, Polesskiĭ VA, Shcherbakova IA, Metel'skaia VA, Kulakova SN, Astakhova TI, Nikitin IuP, Perova NV. Vopr Med Khim; 1989 Jan; 35(5):7-11. PubMed ID: 2617942 [Abstract] [Full Text] [Related]
7. Hypolipidemic activity of 18beta-glycyrrhetinic acid on streptozotocin-induced diabetic rats. Kalaiarasi P, Kaviarasan K, Pugalendi KV. Eur J Pharmacol; 2009 Jun 10; 612(1-3):93-7. PubMed ID: 19361497 [Abstract] [Full Text] [Related]
8. Plasma concentrations of lipids and lipoproteins in newborn kids and female Baladi goats during late pregnancy and onset of lactation. Hussein SA, Azab ME. Dtsch Tierarztl Wochenschr; 1998 Jan 10; 105(1):6-9. PubMed ID: 9499625 [Abstract] [Full Text] [Related]
9. Plasma concentrations of non-esterified fatty acids in chronic renal failure in the United Arab Emirates. Gillett MP, Obineche EN, Khan ST, Abdulle AM. Saudi Med J; 2004 Nov 10; 25(11):1611-6. PubMed ID: 15573187 [Abstract] [Full Text] [Related]
14. The role of dietary oxidized cholesterol and oxidized fatty acids in the development of atherosclerosis. Staprans I, Pan XM, Rapp JH, Feingold KR. Mol Nutr Food Res; 2005 Nov 10; 49(11):1075-82. PubMed ID: 16270280 [Abstract] [Full Text] [Related]
15. Apolipoprotein M predicts pre-beta-HDL formation: studies in type 2 diabetic and nondiabetic subjects. Plomgaard P, Dullaart RP, de Vries R, Groen AK, Dahlbäck B, Nielsen LB. J Intern Med; 2009 Sep 10; 266(3):258-67. PubMed ID: 19457058 [Abstract] [Full Text] [Related]
17. Effect of insulin treatment on plasma oxidized LDL/LDL-cholesterol ratio in type 2 diabetic patients. Galland F, Duvillard L, Petit JM, Lagrost L, Vaillant G, Brun JM, Gambert P, Vergès B. Diabetes Metab; 2006 Dec 10; 32(6):625-31. PubMed ID: 17296517 [Abstract] [Full Text] [Related]
18. Atorvastatin affects low density lipoprotein and non-high density lipoprotein cholesterol relations with apolipoprotein B in type 2 diabetes mellitus: modification by triglycerides and cholesteryl ester transfer protein. Kappelle PJ, Zwang L, Huisman MV, Banga JD, Sluiter WJ, Dallinga-Thie GM, Dullaart RP. Expert Opin Ther Targets; 2009 Jul 10; 13(7):743-51. PubMed ID: 19505224 [Abstract] [Full Text] [Related]
19. Effects of eicosapentaenoic acids on remnant-like particles, cholesterol concentrations and plasma fatty acid composition in patients with diabetes mellitus. Nakamura N, Hamazaki T, Kobayashi M, Ohta M, Okuda K. In Vivo; 1998 Jul 10; 12(3):311-4. PubMed ID: 9706476 [Abstract] [Full Text] [Related]
20. LDL particle size and lipid composition are risk factors for microalbuminuria in normotensive and normocholesterolemic patients with type 2 diabetes. Matsui J, Tamasawa N, Tanabe J, Kasai N, Murakami H, Yamato K, Guan J, Suda T. Diabetes Res Clin Pract; 2004 Dec 10; 66(3):229-36. PubMed ID: 15536019 [Abstract] [Full Text] [Related] Page: [Next] [New Search]